STAAR Surgical Posts Loss-to-Profit Swing on Higher Revenue Across Both Reported Windows

Bottom line

For the three- and six-month windows covered by this 10-Q for STAAR SURGICAL CO (ticker STAA, CIK 0000718937, accession 0000718937-26-000037, fiscal period period-ended-2026-07-03), every headline earnings line in the Condensed Consolidated Statements of Operations flipped from a loss in the prior-year comparatives to a profit in the current period. The change shows up consistently across all four bottom-line measurements that the catalog supports: Earnings Per Share, Diluted (the three-month result and the six-month year-to-date result), Net Income (Loss) Attributable to Parent (the three-month result and the six-month year-to-date result), and Operating Income (Loss) (the three-month result and the six-month year-to-date result). Revenues, the only top-line figure in scope, were also positive in both periods and rose year over year on both the quarter and the six-month view.

The reading is therefore that this filing presents a broad-based swing from loss to profit on a like-for-like basis, paired with higher revenue in each window, with no line in the supported set contradicting that direction.

- The reporting identity is fixed by the filing itself: a 10-Q filed by STAAR SURGICAL CO for period-ended-2026-07-03, available on the public docket under accession 0000718937-26-000037. - The source scope for this section is restricted to the four financial lines named above (Earnings Per Share, Diluted; Net Income (Loss) Attributable to Parent; Operating Income (Loss); Revenues) at the two reported windows (the three-month reporting period and the six-month year-to-date period), each stated alongside its prior-year comparative. - The unaudited Condensed Consolidated Financial Statements are prepared in accordance with U.S. GAAP for interim financial information and the instructions to Form 10-Q, as set out in Note 1, and the reader is directed to the audited prior-year financial statements included in the Company’s Annual Report on Form referenced there for full footnote context.

The filing evidence does not attribute this change to any single cause.

Financial performance

- For the three months ended on the reporting date, Revenues reached $93,535,000 USD, higher than the prior-year comparative of $44,320,000 USD for the three months ended June 27, 2025. Revenues for the six-month year-to-date window reached $187,057,000 USD, higher than $86,909,000 USD for the six months ended June 27, 2025. - Operating Income (Loss) for the three-month window was $10,101,000 USD, a profit compared with the prior-year loss of -$29,964,000 USD, marking a loss-to-profit transition.

Operating Income (Loss) for the six-month window reached $18,080,000 USD, also a profit, compared with a prior-year loss of -$87,365,000 USD. - Net Income (Loss) Attributable to Parent for the quarter was $8,058,000 USD, a profit against the prior-year loss of -$16,812,000 USD. For the six-month period, the figure was $13,264,000 USD, a profit against the prior-year loss of -$71,023,000 USD.

34 per diluted share USD/SHARES in the prior year. 44 per diluted share USD/SHARES in the prior-year period. - The filing evidence does not attribute this change to any single cause.

- On the accounting context side, the company notes it is a single reportable segment managed on a consolidated basis, with the Chief Executive Officer acting as chief operating decision maker and assessing performance against forecasts using net income or, where applicable, operating results. Disaggregation of sales, geographic sales, product sales, and long-lived assets is presented in Note 14 and Note 15, and inventory accounting is governed by the lower-of-cost-and-net-realizable-value policy discussed in Note 3.

- The filing also references investments classified under the fair-value hierarchy in Level 1 and Level 2, with the related accounting policy detailed in Note 2. Vendor concentration risk is flagged in Note 16, and the restructuring, leadership realignment, and cooperation-related charges referenced in the filing connect to the lease and sublease narrative in Note 8 and the other current liabilities discussion in Note 7. - Restructuring, impairment, and related charges were recognized earlier in the fiscal year following changes to the leadership team, cost and discretionary spending reductions, and the termination of the Alcon Merger Agreement and entry into the Broadwood Cooperation Agreement.

The filing characterizes these actions as intended to reposition the company for sustainable growth, with professional service expenses tied to the merger and cooperation agreements cited within the period. Property, plant and equipment matters, including active subleasing efforts, are addressed in Note 5, and capitalized cloud-based software implementation costs are discussed in Note 6. - A recent accounting pronouncement on expense disaggregation disclosures has been adopted on the annual disclosure timeline, with the interim disclosure requirement scheduled for adoption in a subsequent fiscal year, as described in Note 1.

- The filing evidence contains no peer or industry comparison.

Operating drivers and segments

- The filing describes a single operating segment. The Chief Executive Officer is identified as the chief operating decision maker, who manages and allocates resources on a consolidated basis and assesses performance by comparing actual results to forecasts, focusing on net income or, when a net loss is reported, on operating results. - The measure of segment assets is reported as total consolidated assets, and expenditures for additions to long-lived assets, and depreciation and amortization expense, are consistent with the Condensed Statement of Cash Flows; no separate segment asset or segment margin schedule is presented in the cited evidence. - Because the company operates as one segment, segment-level revenue and margin disaggregation appears only through the sales and geographic disclosures in Note 14 and the geographic asset disclosures in Note 15; the source narrative does not provide per-segment operating margins. - Compared with the three months ended June 27, 2025, Revenues in the three months ended July 3, 2026 were higher than the prior period, and the three-month Operating Income (Loss) moved from a loss in the prior-year quarter to a profit in the current quarter, as shown by $44,320,000, $93,535,000, -$29,964,000 and $10,101,000. - Compared with the six months ended June 27, 2025, Revenues in the six months ended July 3, 2026 were higher than the prior period, and the six-month Operating Income (Loss) moved from a loss to a profit, as shown by $86,909,000, $187,057,000, -$87,365,000 and $18,080,000. - The recent accounting standards update discussed in the filing addresses expense disaggregation in footnotes only; it does not change the face of the income statement, and the cited evidence does not quantify any incremental margin impact from adoption, so the profit transition cannot be attributed to that accounting change. The filing evidence does not attribute this change to any single cause.

- Management frames the year-to-date improvement as the product of a multi-step realignment: a leadership team change, a structure realigned to address market needs, a cost and discretionary-spend reduction intended to position the company to return to sustainable growth, and additional restructuring charges connected to the termination of the Alcon merger agreement and the Cooperation Agreement with Broadwood Partners and its affiliates. - The narrative also notes that the company is actively pursuing subleasing opportunities, with further detail cross-referenced to Note 8 – Operating Leases, and that professional service expenses tied to the proposed Alcon merger and the Cooperation Agreement were incurred in the six months ended in the second quarter of the current fiscal year. - Management does not, in the quoted evidence, identify which product lines, geographies, or pricing actions produced the higher revenues or the swing from operating loss to operating profit; the cited notes only point readers to the disaggregation of sales disclosures for further detail. The filing evidence does not attribute this change to any single cause. - The filing does not include a peer-group, market-share, or industry comparison; the only context around the reported margins is the company's own consolidated result and the leadership realignment and cost actions described above. The filing evidence contains no peer or industry comparison. - Independent readers can model profit improvement and the contribution of any restructuring charge using an ROI Calculator, though the cited evidence does not provide a charge figure or a non-GAAP bridge from which to compute it.

LINKS: /finance/roi-calculator/

Cash flow and capital

The filing's liquidity anchor at the balance sheet date is the reported cash and equivalents balance, sized against the working-capital line items that frame the year-to-date cash discussion.

Reported facts: - Cash and Cash Equivalents, at Carrying Value was $148,579,000 USD as of the balance sheet date of July 3, 2026. - Accounts Receivable, after Allowance for Credit Loss, Current was $98,475,000 USD as of the balance sheet date of July 3, 2026. - Accounts Payable, Current was $13,476,000 USD as of the balance sheet date of July 3, 2026. - Net Cash Provided by (Used in) Operating Activities was -$2,005,000 USD for the six months ended July 3, 2026 and -$32,983,000 USD for the six months ended June 27, 2025. - Net Cash Provided by (Used in) Investing Activities was $781,000 USD for the six months ended July 3, 2026 and $60,471,000 USD for the six months ended June 27, 2025. - Net Cash Provided by (Used in) Financing Activities was -$3,195,000 USD for the six months ended July 3, 2026 and -$5,488,000 USD for the six months ended June 27, 2025. - Payments to Acquire Property, Plant, and Equipment were $937,000 USD for the six months ended July 3, 2026 and $3,260,000 USD for the six months ended June 27, 2025.

On the operating side, the year-to-date cash used in operations moved higher than the prior-year comparative — a less negative operating result than the year-ago window, even though both periods remain on the outflow side of the ledger. Investing activity moved in the opposite direction: net cash provided by investing declined versus the prior-year comparative, with both periods staying on the positive side of zero. Within investing, capital expenditures declined relative to the prior-year comparative, indicating a lower level of cash deployed into property, plant, and equipment this year-to-date. Financing activity, for its part, moved higher than the prior-year figure while both periods remained in cash-out territory.

Management explanations in the notes describe a context consistent with this pattern. The cited note on operating leases discusses impairments tied to the decision to exit several leased properties, with one subtenant already in place and the others being actively pursued. The cited note on property, plant, and equipment references construction in process tied to machinery and equipment build-out and validation, with the Company noting it expects to continue investing in system functionality. The cited note on other current liabilities references assets the Company will no longer be using, with the impairment classified within restructuring, impairment and related charges on the income statement. The cited note on cloud-based software describes continued capitalization of implementation costs. The cited note on restructuring references severance obligations payable on a monthly basis through an upcoming period, while the cited note on defined benefit pension plans notes that the Company is not currently required to fund the Japan pension plan.

Analyst inference: the narrowing operating cash outflow alongside the year-to-date narrowing of the bottom-line loss — both transitioning from a loss to a profit on the income side — points to working-capital movements and the restructuring outflows referenced above as the operating-cash context. The filing evidence does not attribute this change to any single cause.

Counter-evidence: the cited note on income taxes and the cited note on revenue disaggregation describe tax-provision matters and a non-cash posture that are not directly mapped to the cash-flow lines above.

Unknowns: - The geographic and product split of cash generation is not directly addressed by the cash-flow statement itself. - The composition of the investing-activity line beyond the reported capex figure cannot be split from the filing evidence, and The filing evidence contains no peer or industry comparison. applies to any cross-company comparison.

Peer and historical context

- Reported facts - For the three-month reporting period, STAAR SURGICAL CO (ticker STAA, filing 10-Q for fiscal period period-ended-2026-07-03, accession 0000718937-26-000037, CIK 0000718937) recorded Revenues of $93,535,000 USD, compared with $44,320,000 USD for the prior-year comparative three-month reporting period. Operating Income (Loss) moved from -$29,964,000 USD to $10,101,000 USD, and Net Income (Loss) Attributable to Parent moved from -$16,812,000 USD to $8,058,000 USD over the same pair of periods. - For the six-month year-to-date period, Revenues were $187,057,000 USD against $86,909,000 USD.

Operating Income (Loss) shifted from -$87,365,000 USD to $18,080,000 USD, and Net Income (Loss) Attributable to Parent shifted from -$71,023,000 USD to $13,264,000 USD. Net Cash Provided by (Used in) Operating Activities was -$32,983,000 USD in the prior year-to-date window and -$2,005,000 USD in the current year-to-date window. - Management explanations - Management commentary in the cited notes points to restructuring-related charges, lease-exit impairments, capitalized cloud-based software, pension obligations in Switzerland and Japan, and the ongoing evaluation of annual disclosure requirements as the operational context surrounding these figures.

None of these notes, however, isolate a single driver for the period-over-period change in any of the headline lines used in this section. - Analyst inference - The quarter-over-quarter and half-year-over-half-year moves sit inside the catalogue of authorised year-over-year relations: Revenues, Operating Income (Loss) and Net Income (Loss) Attributable to Parent each shifted higher in the current period relative to the prior-year comparative on both windows, and the operating-income and net-income lines flipped from a loss in the prior year to a profit in the current year on both windows.

Net Cash Provided by (Used in) Operating Activities also improved (became less negative) on the half-year comparison. Reading these together, the half-year story is consistent with the quarter story — the year-to-date move is not being driven by a single anomalous three-month outcome. - Counter-evidence - The directional language above is read straight from the machine-authorised relations; nothing in this section is asserted as a peer comparison because The filing evidence contains no peer or industry comparison..

The catalyst for the improvement is not separable from the reported numbers on the evidence supplied, so any single-cause read of the swing is replaced by The filing evidence does not attribute this change to any single cause.. - Unknowns - No benchmark against named medical-device peers is available inside the filing evidence, and no prior fiscal year outside the comparative windows listed above is quoted in this section's catalogue.

Scenario analysis

In the central path, the headline top line is materially larger than the prior-year comparative and remains positive on both the three-month reporting period and the six-month year-to-date period, with revenues for the current quarter reaching $93,535,000 USD and revenues for the year-to-date window reaching $187,057,000 USD versus $44,320,000 USD and $86,909,000 USD, respectively. At the bottom line, the loss-to-profit transition that the filings already display is sustained: net income attributable to parent is positive for the three months ended July 3, 2026 at $8,058,000 USD and for the six months ended July 3, 2026 at $13,264,000 USD, against the prior-year losses of -$16,812,000 USD and -$71,023,000 USD. Operating income, diluted EPS, and cash-flow lines move in the same authorized direction as the catalog permits, and the restructuring, impairment and related charges described in the cited notes remain a manageable drag rather than a recurring penalty. Under this scenario the company funds its Note 8 operating-lease commitments, continues the build-out of construction-in-process equipment, and keeps advancing the cloud-based software work tracked in Note 6 without the need to scale back headcount plans disclosed in the cited restructuring context.

A constructive path layers further revenue acceleration on top of the base case, with both the three-month and six-month topline measures expanding relative to the prior-year comparatives already on file. The favorable transition from loss to profit on the net-income line extends into a wider profitability margin, with $8,058,000 USD and $13,264,000 USD sitting comfortably above the prior-year losses of -$16,812,000 USD and -$71,023,000 USD. The cited vendor concentration disclosed in Note 16 proves less binding because supplier diversification and inventory build — described in Note 3 — keep pace with demand. Subleasing progress on the exited leased properties referenced in Note 8 recoups cash sooner, trimming the cash drag from investing activities even as the company continues to invest in property, plant and equipment tracked in Note 5. Geographic diversification called out in Note 15 and Note 14 supports the upside, while defined-benefit obligations under Note 10 remain unfunded as today. Investors can use the ROI Calculator to frame how incremental upside cash flow would compound at different reinvestment rates.

The risk path assumes revenue contracts against the same prior-year comparatives — $93,535,000 USD slipping below $44,320,000 USD and $187,057,000 USD slipping below $86,909,000 USD — which would compress the operating margin and reverse the loss-to-profit transition on net income, pulling $8,058,000 and $13,264,000 back toward the prior-year losses of -$16,812,000 USD and -$71,023,000 USD. Vendor concentration flagged in Note 16 becomes a binding constraint when Note 3 inventory levels prove harder to refresh, and the impairment and subleasing shortfalls noted in Note 8 continue to absorb cash. Pension funding for the Switzerland and Japan plans in Note 10 could become a required outflow if local regulators compel contributions. The available-for-sale portfolio tracked in Note 2 would also face mark-to-market pressure through the fair-value hierarchy in Level 1 and Level 2. Readers can stress-test savings resilience with the Best Savings Template for Recurring Deposits to see how a margin squeeze would erode a cash buffer.

Risks and what to watch

- Whether the operating-lease restructuring discussed under the cited note generates further impairment or subleasing recoveries in the coming period, since the Company has already recorded an impairment tied to exiting several leased properties and is still pursuing subtenants for the remaining space. - Whether the Switzerland and Japan defined benefit pension plans create cash contribution pressure going forward, given that the cited note states the Company is not currently required to contribute to its Japan pension plan — that could change as funded status moves. - The trajectory of $93,535,000 relative to $44,320,000 and of $187,057,000 relative to $86,909,000, since revenue is the headline top-line dimension that supports the net-income swing. - The durability of the bottom-line swing visible in $8,058,000 versus -$16,812,000 and in $13,264,000 versus -$71,023,000, where the prior-year comparative was a loss and the current period is a profit. - Two-vendor concentration risk flagged under the cited note on related-party transactions, which the next filing may either confirm, reduce, or escalate. - Cloud-based software capitalisation activity and amortisation cadence disclosed under the cited note, which can distort period-to-period operating expenses.

Reported facts - For the three months ended July 3, 2026, the Company recorded $8,058,000 in profit versus a loss of -$16,812,000 for the three months ended June 27, 2025. - For the six months ended July 3, 2026, the Company recorded $13,264,000 in profit versus a loss of -$71,023,000 for the six months ended June 27, 2025. - Revenues for the three months ended July 3, 2026 were $93,535,000, higher than $44,320,000 for the prior-year quarter. - Revenues for the six months ended July 3, 2026 were $187,057,000, higher than $86,909,000 for the prior-year half-year.

Management explanations - The Company impaired certain right-of-use assets tied to leased properties it is exiting, recording the charge in restructuring, impairment and related charges on the Condensed Consolidated Statements of Operations. - The impairment measurement relied on market comparables of similar subleased properties, and management obtained a subtenant for one of the exited properties while continuing to pursue subleasing for the others. - Management elected not to include lease extensions in the initial lease valuation unless it was reasonably certain to extend.

Analyst inference - A profit result in the current quarter against a prior-year loss is consistent with the revenue expansion observed in $93,535,000 versus $44,320,000; the year-to-date swing in $13,264,000 relative to -$71,023,000 sits alongside higher half-year revenue at $187,057,000.

Counter-evidence - The headline swing from loss to profit is partly a base-effect phenomenon: prior-year comparables at -$16,812,000 and -$71,023,000 were losses, so a modestly profitable current period mechanically produces a large percentage reversal that the analysis should not over-interpret. - Restructuring and impairment charges — explicitly disclosed under the cited operating-lease note — are non-recurring and bias operating and pre-tax comparisons upward; stripping them out would narrow the headline swing. - Vendor concentration risk, as called out under the cited note on related-party transactions, tempers confidence in the durability of cost-of-revenue performance.

Unknowns - The filing evidence does not attribute this change to any single cause. - The filing evidence contains no peer or industry comparison. - The filing evidence does not disclose segment-level detail for this dimension.

Metrics to watch next period - Whether the year-over-year revenue gap widens or narrows between $93,535,000 and $44,320,000. - Whether net income remains positive at the level of $8,058,000 or reverts toward the loss baseline of -$16,812,000. - Further impairment, subleasing gain or loss, and restructuring cash outflows tied to the leased properties described under the cited note. - Movements in pension funding status and any required contributions to the Switzerland and Japan plans disclosed under the cited pension note. - Vendor concentration metrics referenced under the cited note on related-party transactions.